A phase 2 study of TPIV200/ huFR-1 (a multi-epitope folate receptor alpha vaccine) in combination with durvalumab in patients with platinum resistant ovarian cancer Meeting Abstract
| Authors: | Zamarin, D.; Yeku, O.; O'Cearbhaill, R. E.; Cadoo, K. A.; Gallagher, J.; Kravetz, S.; McDonnell, A.; Troso-Sandoval, T.; Sabbatini, P.; Lichtman, S.; Tew, W.; Makker, V.; Grisham, R. N.; Hyman, D. M.; Aghajanian, C.; Konner, J. |
| Abstract Title: | A phase 2 study of TPIV200/ huFR-1 (a multi-epitope folate receptor alpha vaccine) in combination with durvalumab in patients with platinum resistant ovarian cancer |
| Meeting Title: | 12th Biennial Ovarian Cancer Research Symposium |
| Journal Title: | Clinical Cancer Research |
| Volume: | 25 |
| Issue: | 22 Suppl. |
| Meeting Dates: | 2018 Sep 13-15 |
| Meeting Location: | Seattle, WA |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-11-01 |
| Start Page: | 186 |
| Language: | English |
| ACCESSION: | WOS:000497337700111 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: AP27 -- Source: Wos |
